Supplementary Table S5 from ACYP2 Induces Temozolomide Resistance in Glioblastoma by Promoting PARP1-Mediated DNA Damage Repair

2026 Open access

Read full text
Authors: Mengjun Sui, Qing Cai, Zhiwei Sun, Jinjin Li, Yiyang Zhang, Mengdan Li, Penggao Dai, Gang Li
DOI: 10.1158/1541-7786.30986390
Cited by: 0

Abstract

Supplementary Table S5. The antibodies were used in this article.

Fields of Study & Subjects

PARP inhibition in cancer therapy Glioma Diagnosis and Treatment Drug Transport and Resistance Mechanisms

Publication details

Publisher
American Association for Cancer Research (AACR)
Publication date
2 January 2026